FDA Import Refusal AEK-3721854-0/121/1 — ASPIRE PHARMA LTD
The FDA refused shipment AEK-3721854-0/121/1 from ASPIRE PHARMA LTD (United Kingdom) on Aug 18, 2023. The refused product falls under Drugs and Biologics — DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Aug 18, 2023
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 62ODY26 DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75